When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer

European Journal of Human Genetics

Volumn 24, Issue 11, 2016, Pages 1517-1523

  Meiser, B ^a   Quinn, V F ^a   Gleeson, M ^b   Kirk, J ^c,d   Tucker, K M ^e   Rahman, B ^a   Saunders, C ^f   Watts, K J ^a   Peate, M ^a,g   Geelhoed, E ^f   Barlow Stewart, K ^h   Field, M ⁱ   Harris, M ^j   Antill, Y C ^k   Mitchell, G ^l  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Hunter Family Cancer Service   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ ROYAL NORTH SHORE HOSPITAL   (Australia)

^j SOUTHERN HEALTH   (Australia)

^k CABRINI INSTITUTE   (Australia)

^l PETER MACCALLUM CANCER CENTRE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; BILATERAL MASTECTOMY; BREAST CANCER; CANCER SURGERY; COMPARATIVE STUDY; COPING BEHAVIOR; EDUCATIONAL STATUS; FAMILIAL AWARENESS; FAMILY HISTORY; FEMALE; GENETIC SCREENING; HEALTH CARE ACCESS; HETEROZYGOTE; HUMAN; INTERPERSONAL COMMUNICATION; MASTECTOMY; MEDICAL DECISION MAKING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ADJUSTMENT; QUALITATIVE ANALYSIS; QUALITATIVE RESEARCH; RISK REDUCTION; SEMI STRUCTURED INTERVIEW; SHARING RESULTS WITH RELATIVE; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TREATMENT FOCUSED GENETIC TESTING; TUMOR SUPPRESSOR GENE; ADULT; ATTITUDE TO HEALTH; BREAST NEOPLASMS; GENETICS; MIDDLE AGED; MUTATION; PSYCHOLOGY; QUESTIONNAIRE;

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; SURVEYS AND QUESTIONNAIRES; TRUTH DISCLOSURE;

EID: 84975522851     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2016.69     Document Type: Article

References (29)

1. Robson M, Bradbury A, Arun B, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2015; 33: 3660-3667.
2. National Breast and Ovarian Cancer Centre. Recommendations for Follow-up of Women with Early Breast Cancer. Surry Hills, NSW, Australia: National Breast and Ovarian Cancer Centre, 2010.
3. Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 2003; 138: 1323-1328.
4. Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breastconserving surgery and radiotherapy in BRCA1/2-Associated stage I/II breast cancer [see comment]. J Clin Oncol 2006; 24: 2437-2443.
5. Fong P, Boss D, Yap T, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361: 1-12.
6. Byrski T, Huzarski T, Dent R, et al. Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2014; 147: 401-405.
7. Isakoff S, Mayer E, He L, et al. TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer. J Clin Oncol 2015; 33: 1902-1909.
8. Trainer A, Lewis C, Tucker K, Meiser B, Friedlander M, Ward R. Treatment-focused genetic assessment in breast cancer - The evolving role of the familial cancer services. Nat Rev Clin Oncol 2010; 7: 708-717.
9. Katz S, Kurian A, Morrow M. Decision-making and genetic testing for breast cancer. JAMA 2015; 314: 997-998.
10. Meiser B, Tucker K, Friedlander M, et al. Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Canc Res 2008; 10: 216.
11. Manchanda R, Loggenberg K, Sanderson S, et al. Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial. J Natl Cancer Inst 2015; 107: 379.
12. King M, Levy-Lahad E, Lahad A. Population screening for breast cancer. JAMA 2014; 312: 1091-1092.
13. Hilgart J, Coles B, Iredale R. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2012; 2; CD003721.
14. Hamilton JG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-Analytic review. Health Psychol 2009; 28: 510-518.
15. Schlich-Bakker KJ, Warlam-Rodenhuis CC, van Echtelt J, van den Bout J, Ausems MG, ten Kroode HF. Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer. Eur J Cancer 2006; 42: 2722-2728.
16. Schlich-Bakker KJ, Ausems MG, Schipper M, Ten Kroode HF, Warlam-Rodenhuis CC. BRCA1/2 mutation testing in breast cancer patients: a prospective study of the longterm psychological impact of approach during adjuvant radiotherapy. Breast Cancer Res Treat 2008; 109: 507-514.
17. Shkedi-Rafid S, Gabai-Kapara E, Grinshpun-Cohen J, Levy-Lahad E. BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening. Genet Med 2012; 14: 688-694.
18. Watts K, Meiser B, Mitchell G, et al. How should we discuss genetic testing with women newly diagnosed with breast cancer?. Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer. BMC Cancer 2012; 12: 320.
19. Miles MB, Huberman AM, Saldana J. Qualitative Data Analysis: A Methods Sourcebook, 3rd edn. London: Sage, 2014.
20. Patton M. Qualitative Evaluation and Research Method, 3rd edn. London: Sage Publications, Inc., 2002.
21. Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002; 6: 79-87.
22. Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Leguis E. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women looking back on the pre-Test period and a psychological evaluation. Genet Test 2004; 8: 13-21.
23. Loader S, Shields CG, Rowley PT. Impact of genetic testing for breast-ovarian cancer susceptibility. Genet Test 2004; 8: 1-12.
24. Farrelly A, White V, Meiser B, et al. Unmet support needs and distress among women with a BRCA1/2 mutation. Fam Cancer 2013; 12: 509-518.
25. Metcalfe K, Liede A, Hoodfar E, Scott A, Foulkes W, Narod S. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 2000; 37: 866-874.
26. Werner-Lin A. Formal and informal support needs of young women with BRCA mutations. J Psychosoc Oncol 2008; 26: 111-133.
27. Esplen MJ, Hunter J, Leszcz M, et al. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer 2004; 101: 2327-2340.
28. Landsbergen K, Brunner H, Manders P, et al. Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress. Genet Couns 2010; 21: 423-437.
29. White V, Young M, Farrelly A, et al. Randomized controlled trial of a Telephone-Based Peer-Support Program for women carrying a BRCA1 or BRCA2 mutation: impact on psychological distress. J Clin Oncol 2014; 32: 4073-4080.